Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression
Top Cited Papers
Open Access
- 11 September 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular Cancer
- Vol. 16 (1), 1-16
- https://doi.org/10.1186/s12943-017-0719-3
Abstract
Non-coding RNAs (ncRNAs) have been shown to regulate gene expression involved in tumor progression of multiple malignancies. Our previous studies indicated that large tumor suppressor kinase 1 (LATS1), a core part of Hippo signaling pathway, functions as a tumor suppressor in gastric cancer (GC). But, the underlying molecular mechanisms by which ncRNAs modulate LATS1 expression in GC remain undetermined. The correlation of LATS1 and has-miR-424-5p (miR-424) expression with clinicopathological characteristics and prognosis of GC patients was analyzed by TCGA RNA-sequencing data. A novel circular RNA_LARP4 (circLARP4) was identified to sponge miR-424 by circRNA expression profile and bioinformatic analysis. The binding site between miR-424 and LATS1 or circLARP4 was verified using dual luciferase assay and RNA immunoprecipitation (RIP) assay. The expression and localization of circLARP4 in GC tissues were investigated by fluorescence in situ hybridization (FISH). MTT, colony formation, Transwell and EdU assays were performed to assess the effects of miR-424 or circLARP4 on cell proliferation and invasion. Increased miR-424 expression or decreased LATS1 expression was associated with pathological stage and unfavorable prognosis of GC patients. Ectopic expression of miR-424 promoted proliferation and invasion of GC cells by targeting LATS1 gene. Furthermore, circLARP4 was mainly localized in the cytoplasm and inhibited biological behaviors of GC cells by sponging miR-424. The expression of circLARP4 was downregulated in GC tissues and represented an independent prognostic factor for overall survival of GC patients. circLARP4 may act as a novel tumor suppressive factor and a potential biomarker in GC.Keywords
This publication has 52 references indexed in Scilit:
- Restoration of miR-424 suppresses BCR–ABL activity and sensitizes CML cells to imatinib treatmentCancer Letters, 2015
- Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)The Lancet, 2015
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progressionScientific Reports, 2014
- Hypoxia-induced miR-424 decreases tumor sensitivity to chemotherapy by inhibiting apoptosisCell Death & Disease, 2014
- microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathwayMolecular Cancer, 2014
- MicroRNA-424 Is Down-Regulated in Hepatocellular Carcinoma and Suppresses Cell Migration and Invasion through c-MybPLOS ONE, 2014
- Circular RNA and miR-7 in CancerCancer Research, 2013
- MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1Nature Communications, 2013
- Decreased expression of LATS1 is correlated with the progression and prognosis of gliomaJournal of Experimental & Clinical Cancer Research, 2012